
|Articles|November 1, 2004
D?j? vu all over again—again
Once more, the United States doesn't have enough of a vaccine—this time, flu vaccine. Just as the influenza season was about to start, the bad news hit the headlines: The entire output of the California-based Chiron company's influenza vaccine has been condemned by the authorities in the United Kingdom, where Chiron's vaccine, Fluvinir, is manufactured. US authorities had counted on 100 million doses of flu vaccine this year—up from 87 million available last year. About half that amount was to be supplied by Chiron.
Advertisement
Advertisement
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
Julie Khlevner, MD, discusses the impact of FDA-approved LINZESS for functional constipation
2
Top 5 pediatric health headlines you missed in May 2026
3
Recognizing the skin findings that distinguish pediatric hidradenitis suppurativa
4
FDA approves ensitrelvir for post-exposure prevention of COVID-19 in adolescents and adults
5




